US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Genomics Immunology and Healthcare ETF

41.65

+0.01000.02%

Post-market: 41.650.00000.00%19:59 EDT

Volume:230.10K

Turnover:9.56M

Market Cap:301.96M

PE:- -

High:42.04

Open:41.84

Low:41.25

Close:41.64

52wk High:42.97

52wk Low:23.90

Shares:7.25M

Float Shares:7.25M

Volume Ratio:0.80

T/O Rate:3.17%

Dividend:0.28

Dividend Rate:0.67%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Leerink Sees Life-Science Tools Benefiting from Anthropic's Push into Biology

MediciNova completes LPLV in Phase 2b/3 clinical trial evaluating MN-166

MediciNova Announces Completion of Last Patient, Last Visit in the Double-Blind Portion of the Phase 2b/3 COMBAT-ALS Trial of MN-166 (Ibudilast)

Revolution Medicines (RVMD) Gets a Buy from Goldman Sachs

Mesoblast Wins FDA Nod for New Potency Assay on Ryoncil Batches

Editas slips amid pressure on gene-editing sector after Anthropic update

Moderna CEO's Surprising Comment Gives Clues About Where Drugmaker is Going Next

Moderna rises 4.6%

Early notable gainers among liquid option names on September 23rd

Analysts Offer Insights on Healthcare Companies: Kymera Therapeutics (KYMR), Vertex Pharmaceuticals (VRTX) and Nektar Therapeutics (NKTR)

Wave Life Sciences initiates Phase 2a combination trial of WVE-007

Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX), AnaptysBio (ANAB) and Vertex Pharmaceuticals (VRTX)

These 'Moonshot' Biotech Stocks Could Break Out, Morgan Stanley Says. What Must Go Right.

Vertex Pharmaceuticals Incorporated : Jefferies Raises Target Price to $640 from $633

THOMSON REUTERS

Revolution Medicines Chief Global Commercialization Officer Anthony Mancini Disposes of Common Shares Worth $347,000

Cboe data suggests bullish flow in Moderna with shares up 5.72%

Vertex's Kidney Drug Success Sparks a 22% Surge for This Rival Biotech

New precision medicine venture gives Syngenis added firepower

The West Australian

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Incyte's Colorectal Cancer Program Remains Risky, Long-Term, RBC Says

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/IDNA/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IDNA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDNA\",,,,,undefined,":{"symbol":"IDNA","market":"US","secType":"STK","nameCN":"iShares Genomics Immunology and Healthcare ETF","latestPrice":41.65,"timestamp":1790971200000,"preClose":41.64,"halted":0,"volume":230097,"hourTrading":{"tag":"盘后","latestPrice":41.65,"preClose":41.65,"latestTime":"19:59 EDT","volume":3094,"amount":128861.28,"timestamp":1790985596008,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.00024015369836690706,"floatShares":7250000,"shares":7250000,"eps":0,"marketStatus":"Market Closed","change":0.01,"latestTime":"10-02 16:00:00 EDT","open":41.84,"high":42.04,"low":41.25,"amount":9561511.483608,"amplitude":0.018972,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":41.64,"sharesOutstanding":5100000,"nav":41.483661,"aum":309053274.45,"dividendRate":0.006706,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":41.8183,"preClose":41.64,"latestTime":"09:24 EDT","volume":122,"amount":5156.36538,"timestamp":1790947482007,"change":0.1783,"changeRate":0.004282,"amplitude":0.028206},"postHourTrading":{"tag":"盘后","latestPrice":41.65,"preClose":41.65,"latestTime":"19:59 EDT","volume":3094,"amount":128861.28,"timestamp":1790985596008,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.8041356708242576,"impliedVol":0.1282,"impliedVolPercentile":0.243},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDNA\",,,,,undefined,":{"symbol":"IDNA","floatShares":7250000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.8041356708242576,"shares":7250000,"dividePrice":0.2793,"high":42.04,"amplitude":0.018972,"preClose":41.64,"low":41.25,"week52Low":23.9,"pbRate":"--","week52High":42.97,"institutionHeld":0,"latestPrice":41.65,"eps":0,"divideRate":0.006706,"volume":230097,"delay":0,"ttmEps":0,"open":41.84,"prevYearClose":26.19,"prevWeekClose":41.77,"prevMonthClose":42.32,"prevQuarterClose":42.32,"fiveDayClose":41.77,"twentyDayClose":40.29,"sixtyDayClose":34.5},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IDNA\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"IDNA","amount":0.125421,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2025-12-16","symbol":"IDNA","amount":0.155456,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-06-16","symbol":"IDNA","amount":0.152909,"announcedDate":"2025-06-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-16","defaultRemindTime":1750080600000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-20","payableDate":"2025-06-16","currency":"USD","dateTimestamp":1750046400000,"payDate":"2025-06-20"},{"date":"2024-12-17","symbol":"IDNA","amount":0.11105,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-20"},{"date":"2024-06-11","symbol":"IDNA","amount":0.11144,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-11","defaultRemindTime":1718112600000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-17","payableDate":"2024-06-11","currency":"USD","dateTimestamp":1718078400000,"payDate":"2024-06-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IDNA\",market:\"US\",,,undefined,":[{"executeDate":"2019-12-16","recordDate":"2019-12-17","paymentDate":"2019-12-20","value":0.237063,"currency":"USD"},{"executeDate":"2020-06-15","recordDate":"2020-06-16","paymentDate":"2020-06-19","value":0.083667,"currency":"USD"},{"executeDate":"2020-12-14","recordDate":"2020-12-15","paymentDate":"2020-12-18","value":0.036209,"currency":"USD"},{"executeDate":"2021-06-10","recordDate":"2021-06-11","paymentDate":"2021-06-16","value":0.052145,"currency":"USD"},{"executeDate":"2021-12-13","recordDate":"2021-12-14","paymentDate":"2021-12-17","value":0.256358,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IDNA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IDNA\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669462947","title":"Leerink Sees Life-Science Tools Benefiting from Anthropic's Push into Biology","url":"https://stock-news.laohu8.com/highlight/detail?id=2669462947","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669462947?lang=en_us&edition=fundamental","pubTime":"2026-09-24 19:04","pubTimestamp":1790247866,"startTime":"0","endTime":"0","summary":"BUZZ-Leerink sees life-science tools benefiting from Anthropic's push into biology** Leerink Partners says Anthropic's growing focus on biology could boost demand for laboratory automation, experiments and large-scale data needed to validate AI predictions** Brokerage sees biotech firm Twist BioscienceTWST.Oas the \"single most important beneficiary\", citing demand for synthetic DNA used to turn AI-designed proteins into testable molecules** Says Anthropic is funding laboratory testing of 5,000 protein designs using Twist's synthetic DNA, highlighting the company's role in AI-driven drug discovery** Leerink says Anthropic's Claude analyzed complex laboratory data in 19-23 minutes, potentially allowing researchers to move more quickly to subsequent experiments** Brokerage says early protein-design results are promising, but more data and lab testing will be needed to develop formats suitable for medicines","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nL4N45G0U3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARKG","IDNA","WDNA","BK4585","BK4139","TWST","BK4588","GNOM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669461761","title":"MediciNova completes LPLV in Phase 2b/3 clinical trial evaluating MN-166","url":"https://stock-news.laohu8.com/highlight/detail?id=2669461761","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669461761?lang=en_us&edition=fundamental","pubTime":"2026-09-24 18:10","pubTimestamp":1790244648,"startTime":"0","endTime":"0","summary":"MediciNova (MNOV) announced the completion of the last patient, last visit in the double-blind portion of COMBAT-ALS, a Phase 2b/3 clinical trial e...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/medicinova-completes-lplv-in-phase-2b-3-clinical-trial-evaluating-mn-166-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/medicinova-completes-lplv-in-phase-2b-3-clinical-trial-evaluating-mn-166-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MNOV","BK4139","MEDX","NVIB","GDOC","HYLG","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669461514","title":"MediciNova Announces Completion of Last Patient, Last Visit in the Double-Blind Portion of the Phase 2b/3 COMBAT-ALS Trial of MN-166 (Ibudilast)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669461514","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669461514?lang=en_us&edition=fundamental","pubTime":"2026-09-24 18:00","pubTimestamp":1790244000,"startTime":"0","endTime":"0","summary":"LA JOLLA, Calif., Sept.  24, 2026 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchang","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/24/3368112/7767/en/medicinova-announces-completion-of-last-patient-last-visit-in-the-double-blind-portion-of-the-phase-2b-3-combat-als-trial-of-mn-166-ibudilast.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1720051108.HKD","LU0210528500.USD","IE00B3S45H60.SGD","CAFS","LU0106831901.USD","LU1244550221.USD","LU2089283258.USD","LU1989772840.SGD","LU1720051017.SGD","LU0320765646.SGD","IAI","LU0234570918.USD","LU1162221912.USD","LU1732800096.USD","LU2264538146.SGD","LU1244550577.SGD","BMED","KBWB","LU2111349929.HKD","ARDS","LU0795875086.SGD","MEDX","LU0882574139.USD","EMA","BK4581","BK4588","LU2023251221.USD","LU1363072403.SGD","LU0006306889.USD","LU0557290698.USD","LU2357305700.SGD","IDNA","GDOC","NVIB","HYLG","LU0314104364.USD","MNOV","LU0528227936.USD","LU0795875169.SGD","LU1988902786.USD","LU0053666078.USD","LU0912757837.SGD","BK4516","LU0106261372.USD","LU0971096721.USD","LU2133065610.SGD","BK4504","LU0158827781.USD","IE00BKVL7J92.USD","LU0225283273.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669918463","title":"Revolution Medicines (RVMD) Gets a Buy from Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2669918463","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669918463?lang=en_us&edition=fundamental","pubTime":"2026-09-24 16:35","pubTimestamp":1790238933,"startTime":"0","endTime":"0","summary":"Goldman Sachs analyst Andrea Newkirk resumed coverage with a Buy rating on Revolution Medicines today and set a price target of $267.00. Newkirk co...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/revolution-medicines-rvmd-gets-a-buy-from-goldman-sachs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/revolution-medicines-rvmd-gets-a-buy-from-goldman-sachs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1668664300.SGD","BK4127","LU2237443622.USD","LU1868836757.USD","IE00BSNM7G36.USD","LU2896262040.SGD","LU0942090050.USD","IE00BJJMRZ35.SGD","LU1804176565.USD","LU1144417596.USD","LU0096364046.USD","LU0868494708.USD","LU2237443382.USD","BK4588","BBH","IE00BFXG1179.USD","CANC","LU0345770993.USD","LU0210536198.USD","LU0251142724.SGD","IE0009354923.USD","LU0109394709.USD","IE00B2B36J28.USD","IE0002270589.USD","IE0034235188.USD","IE00BJT1NW94.SGD","LU0742534661.SGD","PTH","GSX","LU1894683264.USD","LU2750360997.AUD","LU1791807156.HKD","LU0061475181.USD","BK4552","IE00BFTCPJ56.SGD","IE0004086264.USD","LU2471134523.USD","LU0345770308.USD","LU2237438978.USD","LU1868836591.USD","BK4550","LU1894683348.USD","LU0251131958.USD","BK4533","LU2237443895.HKD","LU0106831901.USD","IE00B19Z3B42.SGD","LU2237443978.SGD","RVMD","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669437128","title":"Mesoblast Wins FDA Nod for New Potency Assay on Ryoncil Batches","url":"https://stock-news.laohu8.com/highlight/detail?id=2669437128","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669437128?lang=en_us&edition=fundamental","pubTime":"2026-09-24 08:30","pubTimestamp":1790209807,"startTime":"0","endTime":"0","summary":"An announcement from Mesoblast Limited ( ($AU:MSB) ) is now available. Mesoblast has secured U.S. FDA approval for a new T-cell Proliferation Inhib...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mesoblast-wins-fda-nod-for-new-potency-assay-on-ryoncil-batches?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mesoblast-wins-fda-nod-for-new-potency-assay-on-ryoncil-batches?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FRTY","BK4585","MRNX","IDNA","XLVX","IBB","MEDI","BBP","RSPH","LABU","IYH","TBXU","LFSC","PSCH","BMED","TECB","BK4139","IEIH","GNMX","MESO","BK4588","GDOC","SYNB","MRNY","PINK","NVIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669435367","title":"Editas slips amid pressure on gene-editing sector after Anthropic update","url":"https://stock-news.laohu8.com/highlight/detail?id=2669435367","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669435367?lang=en_us&edition=fundamental","pubTime":"2026-09-24 02:55","pubTimestamp":1790189712,"startTime":"0","endTime":"0","summary":"Editas Medicine (EDIT) is trading lower alongside other gene editing peers after Anthropic shared early findings on a CRISPR like enzyme system. An...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/editas-slips-amid-pressure-on-gene-editing-sector-after-anthropic-update-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/editas-slips-amid-pressure-on-gene-editing-sector-after-anthropic-update-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4139","BK4556","IDNA","SYNB","EDIT","BK4611","LU1861558580.USD","GNMX","CRSP","BK4585","LU1861559042.SGD","WDNA","HELX","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669480207","title":"Moderna CEO's Surprising Comment Gives Clues About Where Drugmaker is Going Next","url":"https://stock-news.laohu8.com/highlight/detail?id=2669480207","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669480207?lang=en_us&edition=fundamental","pubTime":"2026-09-24 00:53","pubTimestamp":1790182380,"startTime":"0","endTime":"0","summary":"Moderna CEO Stéphane Bancel said the company was never just about Covid-19 vaccines, and investors appeared to be catching on.Speaking at Bernstein's annual healthcare conference on Wednesday, Bancel ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","MRNA","BK4568","BK4139","BK4588","MRNX","BK4501","BK4534","IDNA","LGHT","BK4548","BK4532","BK4551","GNOM","WDNA","MRNY","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669484897","title":"Moderna rises 4.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669484897","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669484897?lang=en_us&edition=fundamental","pubTime":"2026-09-23 22:05","pubTimestamp":1790172329,"startTime":"0","endTime":"0","summary":"Moderna (MRNA) is up 4.6%, or $8.44 to $191.00. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial new...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderna-rises-4-6-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderna-rises-4-6-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LGHT","BK4139","BK4534","WDNA","MRNA","BK4551","BK4568","GNOM","BK4585","MRNY","IDNA","BK4548","BK4501","BK4532","MRNX","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669948489","title":"Early notable gainers among liquid option names on September 23rd","url":"https://stock-news.laohu8.com/highlight/detail?id=2669948489","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669948489?lang=en_us&edition=fundamental","pubTime":"2026-09-23 21:55","pubTimestamp":1790171726,"startTime":"0","endTime":"0","summary":"Notable gainers among liquid option names this morning include Moderna (MRNA) $191.25 +8.69, Veeva (VEEV) $270.83 +9.92, Palantir Technologies (PLT...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/early-notable-gainers-among-liquid-option-names-on-september-23rd-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/early-notable-gainers-among-liquid-option-names-on-september-23rd-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B19Z9Z06.USD","BK4528","BK4532","BK4504","BK4548","SPLTRmain","LU0006306889.USD","LU1989764664.SGD","LGHT","IDNA","PLTL","LU1861558580.USD","MRNX","IE00B894F039.SGD","BK4613","PLYY","BK4568","IE00BZ9MQY76.HKD","PLTW","PLTR","BK4167","LU0266013472.USD","IE00B19Z9P08.USD","PLTY","PLTI","LU0289739699.SGD","IGV","PLTG","AIPI","SHLD","EKG","PLTD","BK4543","LU0170899867.USD","BK4585","EYES","PLT","LU0106261372.USD","PLTA","BK4023","MRNY","LU1861559042.SGD","PLTZ","GNOM","BK4533","BK4139","BK4551","PTIR","BK4534","BK4501","BK4588","LU0058720904.USD","GUNZ","BK4547","MRNA","VEEV","WDNA","PLOO","LU1989764748.USD","PLTU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669648508","title":"Analysts Offer Insights on Healthcare Companies: Kymera Therapeutics (KYMR), Vertex Pharmaceuticals (VRTX) and Nektar Therapeutics (NKTR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669648508","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669648508?lang=en_us&edition=fundamental","pubTime":"2026-09-23 20:30","pubTimestamp":1790166641,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Kymera Therapeutics (KYMR), Vertex Pharmaceuticals (VRTX) and Nek...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-kymera-therapeutics-kymr-vertex-pharmaceuticals-vrtx-and-nektar-therapeutics-nktr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-kymera-therapeutics-kymr-vertex-pharmaceuticals-vrtx-and-nektar-therapeutics-nktr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B19Z3581.USD","BK4139","LU0757428866.USD","LU2417539215.USD","VERX","LU0289739699.SGD","LU1559883803.SGD","SG9999001176.SGD","LABU","BBH","LU0109394709.USD","NKTR","IE0002270589.USD","VRTX","BK4585","XBI","GNMX","XLV","IBB","LU2362541513.USD","LU0256863811.USD","BIB","LU0234570918.USD","SG9999001176.USD","BK4533","LU0823416689.USD","TBXU","IBBQ","LU0061475181.USD","IDNA","LU2237438978.USD","LU0417517546.SGD","IE0002141913.USD","KYMR","LU0432979614.USD","BK4007","LU1674673428.USD","IE00BZ9MQY76.HKD","LU2324357040.USD","HCSG","LU2089984988.USD","LU2362541273.HKD","PBE","BK4023","IE00BJJMRZ35.SGD","LU1035775433.USD","LU1069344957.HKD","IE00B19Z3B42.SGD","IE00B894F039.SGD","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669882944","title":"Wave Life Sciences initiates Phase 2a combination trial of WVE-007","url":"https://stock-news.laohu8.com/highlight/detail?id=2669882944","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669882944?lang=en_us&edition=fundamental","pubTime":"2026-09-23 19:35","pubTimestamp":1790163326,"startTime":"0","endTime":"0","summary":"Wave Life Sciences (WVE) announced the initiation of its Phase 2a clinical trial evaluating WVE-007, an investigational GalNAc-siRNA, in combinatio...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/wave-life-sciences-initiates-phase-2a-combination-trial-of-wve-007-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/wave-life-sciences-initiates-phase-2a-combination-trial-of-wve-007-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDX","NVIB","HYLG","WVE","GDOC","BK4007","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669711101","title":"Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX), AnaptysBio (ANAB) and Vertex Pharmaceuticals (VRTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669711101","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669711101?lang=en_us&edition=fundamental","pubTime":"2026-09-23 17:10","pubTimestamp":1790154626,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Quest Diagnostics (DGX), AnaptysBio (ANAB) and Verte...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-quest-diagnostics-dgx-anaptysbio-anab-and-vertex-pharmaceuticals-vrtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-quest-diagnostics-dgx-anaptysbio-anab-and-vertex-pharmaceuticals-vrtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0109394709.USD","IE00B19Z3B42.SGD","LABU","IE00BZ9MQY76.HKD","BBH","IBBQ","IE00B2B36J28.USD","PBE","VRTX","XLV","LU2506952170.USD","BK4139","FFTY","IE00BJJMRZ35.SGD","LU2456880835.USD","LU0823417737.USD","IBB","LU2462157665.USD","TBXU","IE0002270589.USD","SG9999001176.SGD","BK4567","LU0823417653.USD","SGXZ57979304.SGD","LU1854103824.USD","XBI","IE0009355771.USD","BIB","VERX","LU2506952097.USD","LU1585245621.USD","LU0823416689.USD","LU0234570918.USD","GNMX","ANAB","LU1035775433.USD","BK4583","LU2089984988.USD","LU0289739699.SGD","HCSG","LU0757428866.USD","LU0079474960.USD","LU1815336091.USD","DGX","IDNA","IE00BJT1NW94.SGD","SG9999001176.USD","LU2506951875.HKD","LU1093756325.SGD","LU0417517546.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669177094","title":"These 'Moonshot' Biotech Stocks Could Break Out, Morgan Stanley Says. What Must Go Right.","url":"https://stock-news.laohu8.com/highlight/detail?id=2669177094","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669177094?lang=en_us&edition=fundamental","pubTime":"2026-09-23 13:45","pubTimestamp":1790142300,"startTime":"0","endTime":"0","summary":"From speculation over mergers and acquisitions to the hype surrounding clinical readouts, it seems biotechnology stocks are all the rage this year.The iShares Biotechnology exchange-traded fund has ri","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234570918.USD","LU0210528500.USD","XBI","BK4501","IBB","BK4534","IDNA","LGHT","LU0795875169.SGD","LU1548497426.USD","BK4548","BK4551","GNOM","IE00B3S45H60.SGD","ARWR","LU2347655156.SGD","LU0158827948.USD","LU1074936037.SGD","MRNA","LU1244550494.USD","MS","BK4504","IE00BKVL7J92.USD","IE00B775SV38.USD","ARGX","MRNY","BK4585","LU1732800096.USD","BK4568","FMED","LU1791710582.SGD","IAI","LU1244550221.USD","LU0006306889.USD","KBWB","BK4532","OZEM","LU1989772840.SGD","TBXU","THNR","MRNX","LU1720051017.SGD","LU2357305700.SGD","LU0109394709.USD","VKTX","IE00B4R5TH58.HKD","LU0098860793.USD","WDNA","LU1988902786.USD","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669999174","title":"Vertex Pharmaceuticals Incorporated : Jefferies Raises Target Price to $640 from $633","url":"https://stock-news.laohu8.com/highlight/detail?id=2669999174","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669999174?lang=en_us&edition=fundamental","pubTime":"2026-09-23 11:36","pubTimestamp":1790134588,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nFWN45E0RF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2468319806.SGD","LU0234570918.USD","BK4585","IDNA","IE00B19Z9P08.USD","IBB","BIB","IE00BZ9MQY76.HKD","PBE","LU1674673428.USD","LU1069344957.HKD","LU2462157665.USD","LU0320765992.SGD","SG9999001176.USD","VRTX","LU0061475181.USD","IE00B4R5TH58.HKD","LU2362540622.SGD","IE00B19Z3581.USD","GNMX","LU0889565916.HKD","LU0432979614.USD","LU1035775433.USD","LU2456880835.USD","IE00B19Z3B42.SGD","IE0002141913.USD","LU2417539215.USD","IE0009355771.USD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU1093756168.USD","IE0002270589.USD","LU0058720904.USD","SGXZ57979304.SGD","BK4588","LU1585245621.USD","TBXU","BBH","LU0109394709.USD","LU2362541273.HKD","IE00B19Z9Z06.USD","LU2237438978.USD","BK4139","SG9999013999.USD","IE00BFTCPJ56.SGD","BK4567","LU1093756325.SGD","IE00B894F039.SGD","LU1778281490.HKD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669120310","title":"Revolution Medicines Chief Global Commercialization Officer Anthony Mancini Disposes of Common Shares Worth $347,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2669120310","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669120310?lang=en_us&edition=fundamental","pubTime":"2026-09-23 06:00","pubTimestamp":1790114446,"startTime":"0","endTime":"0","summary":"Revolution Medicines Chief Global Commercialization Officer Anthony Mancini disposes of common shares worth $347,000Revolution Medicines Chief Global Commercialization Officer Anthony Mancini sold 1,7","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL64Mcy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Revolution Medicines Chief Global Commercialization Officer Anthony Mancini Disposes of Common Shares Worth $347,000","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","LU0889565916.HKD","RVMD","IDNA","IE0009355771.USD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU0320765992.SGD","IE00BJT1NW94.SGD","LU0109394709.USD","PTH","BK4139","CANC","IE0009354923.USD","IE0002141913.USD","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669312925","title":"Cboe data suggests bullish flow in Moderna with shares up 5.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669312925","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669312925?lang=en_us&edition=fundamental","pubTime":"2026-09-23 01:45","pubTimestamp":1790099113,"startTime":"0","endTime":"0","summary":"Cboe data suggests bullish flow in Moderna (MRNA), with shares up $9.88, or 5.72%, near $182.82. Options volume running well above average with 200...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cboe-data-suggests-bullish-flow-in-moderna-with-shares-up-5-72-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cboe-data-suggests-bullish-flow-in-moderna-with-shares-up-5-72-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4548","GNOM","MRNY","BK4568","LGHT","BK4585","BK4533","BK4534","BK4551","BK4588","WDNA","MRNX","MRNA","BK4501","IDNA","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669412656","title":"Vertex's Kidney Drug Success Sparks a 22% Surge for This Rival Biotech","url":"https://stock-news.laohu8.com/highlight/detail?id=2669412656","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669412656?lang=en_us&edition=fundamental","pubTime":"2026-09-23 00:47","pubTimestamp":1790095620,"startTime":"0","endTime":"0","summary":"Shares of biopharmaceutical company Maze Therapeutics jumped after competitor Vertex Pharmaceuticals reported positive study results for its kidney disease drug, signaling strong commercial potential ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","IE0002141913.USD","SGXZ57979304.SGD","IE00B19Z9Z06.USD","IDNA","LU0889565916.HKD","TBXU","BK4588","LU2362541513.USD","LU1035775433.USD","LU2462157665.USD","LU0079474960.USD","LU0256863811.USD","LU1778281490.HKD","VRTX","LU1093756168.USD","LU1674673428.USD","BK4532","XBI","PBE","LU1430594728.SGD","BK4567","LU2324357040.USD","IE00B19Z3581.USD","IE00BFTCPJ56.SGD","LU2236285917.USD","LU1815336091.USD","IE00BJT1NW94.SGD","IE00BZ9MQY76.HKD","LU0234570918.USD","LU1585245621.USD","IBB","LU2089984988.USD","BIB","LU0058720904.USD","LU1069344957.HKD","GNMX","LU2456880835.USD","IBBQ","BK4023","VERX","LU2237438978.USD","IE0009355771.USD","LU0289739699.SGD","BK4585","IE00B2B36J28.USD","MAZE","LU1559883803.SGD","IE00B894F039.SGD","LU0432979614.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669175122","title":"New precision medicine venture gives Syngenis added firepower","url":"https://stock-news.laohu8.com/highlight/detail?id=2669175122","media":"The West Australian","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669175122?lang=en_us&edition=fundamental","pubTime":"2026-09-23 00:27","pubTimestamp":1790094446,"startTime":"0","endTime":"0","summary":"Syngenis has joined the renowned Perron Institute and Gene S founders in a precision-medicine venture that puts its integrated DNA and RNA platform to work and opens the door to recurring manufacturing revenue.","market":"hk","thumbnail":"https://images.thewest.com.au/publication/C-22912933/bcb694b9b6d3ad9e7ac40e225d21b3d9b69e7435.jpg","type":0,"news_type":0,"thumbnails":["https://images.thewest.com.au/publication/C-22912933/bcb694b9b6d3ad9e7ac40e225d21b3d9b69e7435.jpg"],"rights":{"source":"thewest_stock","url":"https://thewest.com.au/business/bulls-n-bears/new-precision-medicine-venture-gives-syngenis-added-firepower-c-22912933","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thewest.com.au/business/bulls-n-bears/new-precision-medicine-venture-gives-syngenis-added-firepower-c-22912933","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"thewest_stock","symbols":["IBB","IDNA","IMLC.AU","GNOM","IIGF.AU","BBOZ.AU","STW.AU","MEDX","GIVE.AU","SLF.AU","E200.AU","OZR.AU","HTEC","XT","BEAR.AU","FDIF","JDOC","OZF.AU","XKO.AU","BK4585","DACE.AU","VAP.AU","ZYAU.AU","EES","HELX","BMED","QFN.AU","IISV.AU","ADHD","TMAT","BK4588","IOZ.AU","LFSC","EIGA.AU","VAS.AU","SYNB","GEAR.AU","QRE.AU","WDNA","GNMX","XJO.AU","PBE","XAO.AU","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669591125","title":"S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT","url":"https://stock-news.laohu8.com/highlight/detail?id=2669591125","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669591125?lang=en_us&edition=fundamental","pubTime":"2026-09-23 00:00","pubTimestamp":1790092809,"startTime":"0","endTime":"0","summary":"BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDTS&P 500.SPXTop PerformersPercent ChangeMonolithic Power Systems IncMPWR.OQ+7.8%AutoZone, Inc.AZO.N+6.1%SanDisk CorporationSNDK.OQ+5.8%Moderna, Inc.MRNA.OQ+5.7%O'Reilly Automotive, Inc.ORLY.OQ+4.4%Bottom PerformersPercent ChangeGen Digital Inc.GEN.OQ-6.4%Allstate CorpALL.N-6.1%The Charles Schwab CorporationSCHW.N-6.0%Expedia Group, Inc.EXPE.OQ-5.8%Cisco Systems IncCSCO.OQ-5.5%As of 12:00 p.m., the S&P 500.SPXlost 3.60 points, or 0.05%, to 7,761.10 and had posted 8 new 52-week highs and 10 new lows.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL8N45E192:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203345920.USD","SFY","LU0477156953.USD","FSMD","IE00BFXG0V08.USD","ALLW","LU2264538146.SGD","LU1674673428.USD","SPLV","BK4107","LU2322448957.HKD","LU0942090050.USD","HIBS","GSLC","LU1585245621.USD","SSO","IE000SO60NU8.SGD","SG9999015986.USD","LU1791807156.HKD","ORLY","IE00BYQQ9H92.USD","LU2108987350.USD","LU0868494708.USD","IJR","LU0353189680.USD","LU0648001328.SGD","BK4515","LU2543165471.USD","LU1880398554.USD","VBK","DISK","IE000M9KFDE8.USD","IVW","LU1934455277.USD","LU1868837300.USD","LU1868836757.USD","BK4141","LU0971096721.USD","GPIX","LU0070302665.USD","SPYU","LU0314106906.USD","LU1883839398.USD","VEU","LU1506573853.SGD","LU0965509101.SGD","SPYM","BK4548","IE00B7SZLL34.SGD","SPY","LU1934455863.HKD","LU0731783394.SGD","LU2360106780.USD","RSPA","XDTE","HIBL","SG9999001077.SGD","LU1153585028.USD","LU2290526834.HKD","DMAX","BK4525","BK4533","LU2456880835.USD","IE00BFXG1179.USD","LU0053666078.USD","MRNA","LU1236620750.USD","IE00B1BXHZ80.USD","LU1674673691.USD","IE00BDGV0183.EUR","BK4579","SNDU","SPUS","LU2102340556.USD","MPWR","SNXX","LU2247934214.USD","IE0000B7K699.USD","BK4612","SG9999015945.SGD","IAK","MPWC","AZO","DBSC","BK4560","IE00B19Z3B42.SGD","ALL","QQQG","MRNX","LU0061475181.USD","LU2089985449.USD","EXPE","BK4550","SPXL","SCHX","VTV","SPYQ","LU2286300806.USD","LU0251142724.SGD","LU0048573561.USD","LU0234570918.USD","SPYV","LU2063271972.USD","LU0234572021.USD","SPXU","LU1988902786.USD","LU0081259029.USD","LU0098860793.USD","SG9999002232.USD","LU0054578231.USD","IE0002270589.USD","LU1244550494.USD","LU1267930573.SGD","LU1064131342.USD","LU1032955483.USD","IE00BN0W2V16.EUR","IE00BKVL7J92.USD","CIBR","OPTZ","BK4532","CSCL","IE00B5TLWC47.USD","LU0742534661.SGD","LU1074936037.SGD","HK0000819398.USD","NOBL","LU0868494617.USD","LU2272731782.SGD","MMAX","LU1599440770.SGD","LU0320765646.SGD","IE00BVYPNW00.USD","LU0985320562.USD","LU2506951875.HKD","IVE","JEPI","LU0965508806.USD","LU1778281490.HKD","CNAV","LU2237443895.HKD","LU2272731865.HKD","LU0963586101.USD","SPGP","BK4504","ITOT","LU2236285917.USD","RSPN","BK4127","SG9999015978.USD","IAI","SG9999001424.SGD","BK4139","TSPY","SG9999014039.USD","LU0345770993.USD","LU2360107168.USD","LU2250418816.HKD","VOO","XLG","LU1066051811.HKD","LU0950375773.USD","IJH","RSPU","COWG","LU1069347547.HKD","LU1868837136.USD","LU0208291251.USD","LU1868836591.USD","SH","IDNA","YSPY","MPWX","LU1221951046.USD","LU0861579265.USD","WDNA","MOAT","LU0128525929.USD","SMAX","LU0708994859.HKD","LU2272731600.USD","IYZ","SNDK","LU2463526074.USD","IE00B3T34201.USD","LU0345774631.USD","LU1037948541.HKD","GNOM","IE000F7OJYX1.SGD","CSCS","LU1668664300.SGD","BK4097","LGHT","ETFT","BK4527","LU0640476718.USD","SNDC","LU2506952097.USD","SCHB","LU2237443978.SGD","LU0310800379.SGD","IE00BVYPNV92.GBP","RSP","LU1861215975.USD","LU1162221912.USD","SDS","LU2931357623.SGD","LU0353189763.USD","LU1201861249.SGD","LU0265550946.USD","BK4501","BK4581","MRNY","LU2237443622.USD","CSCO","BK4214","LU0170899867.USD","PEJ","LU0320765489.SGD","LU1992135472.HKD","IVV","LU0792757196.USD","IE000MB6IJN5.SGD","SG9999001440.SGD","SNDQ","TMSL","LU1894683348.USD","LU0265550359.USD","SPYH","SG9999014021.USD","LU0980610538.SGD","LU1066051225.USD","LU0056508442.USD","BK4568","SNDG","LU0274383776.USD","LU0130102774.USD","LU1868836914.USD","AWAY","IE00BN0W2W23.USD","LU1046421795.USD","LU0320765059.SGD","LU1235294995.USD","LU0889566641.SGD","LU1699723380.USD","BK4142","LU1823568750.SGD","BK4588","LU0345774391.USD","IE00B19Z3581.USD","IE00BGHQF631.EUR","IE00BZ1G4Q59.USD","LU1221951129.SGD","SG9999014005.SGD","LU0130517989.USD","SPHD","BK4170","LU2417539215.USD","SPHQ","VTI","LU2506951958.HKD","LU2360107671.USD","IE00BN0W2T93.GBP","LU1037948897.HKD","SCHW","LU0672654240.SGD","LU1066053197.SGD","LU2237443549.SGD","LU1116320901.HKD","IE000BZT7R73.USD","ACWI","LU0106831901.USD","LU2381873111.SGD","LU1236620834.HKD","BMAY","SPMO","SPYD","VOOG","SPUU","SPYG","LU1116320737.USD","04333",".SPX","LU1861217088.USD","SG9999002224.SGD","LU1280957306.USD","SPXS","LU0029864427.USD","LU1861220033.SGD","XYLD","LU0109391861.USD","IE00BSNM7G36.USD","LU1929549753.HKD","VV","LU1363072403.SGD","SPDN","SG9999015952.SGD","LU0348723411.USD","BK4585","LU1267930813.SGD","LU1934455194.USD","AIQ","LU1430594728.SGD","BK4551","LU0203347892.USD","BK4534","IE00BD6J9T35.USD","LU2462157665.USD","LU0251131958.USD","LU1035773651.USD","LU0965509010.AUD","LU1059921491.USD","LU2506952170.USD","PTF","LU2473716301.USD","SCHM","LU1992135399.USD","LU2355687059.USD","IE000WAW04H5.SGD","LU2237443465.HKD","BK4589","LU2237443382.USD","LU0823417737.USD","IE00B42XCP33.USD","IE00B3PB1722.GBP","LU1852331112.SGD","LU0266013472.USD","LU1196500208.SGD","LU0345770308.USD","FCUS","GEN","LU0965509283.SGD","LU1861220207.SGD","LU0096364046.USD","LU1880398471.USD","LU1894683264.USD","LU0823417653.USD","LU0708995401.HKD","LU2322448791.USD","IE00BFMHRM44.USD","LU1571399168.USD","LU1066051498.USD","SCHA","LU2087625088.SGD","LU0011850046.USD","LU1267930730.SGD","LU1244550221.USD","BK4020","SG9999014013.SGD","UPRO","LU1244550577.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669123074","title":"Incyte's Colorectal Cancer Program Remains Risky, Long-Term, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2669123074","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669123074?lang=en_us&edition=fundamental","pubTime":"2026-09-22 23:45","pubTimestamp":1790091909,"startTime":"0","endTime":"0","summary":"Incyte's  colorectal cancer or CRC programs remain \"risky and more long-term,\" RBC Capital Markets said in a Tuesday note, while expectations for upcoming pancreatic cancer data remain elevated.The company is set to present data on its oncology programs at the upcoming European Society for Medical Oncology or ESMO Congress, with investors expecting improved efficacy from its '734 KRAS G12D inhibitor. Incyte is evaluating '734 in CRC and pancreatic ductal adenocarcinoma or PDAC, while its '890 program is being studied in CRC, according to the note.For PDAC, RBC expects overall response rates or ORR to exceed 80%, compared with 82% for rival zoldonrasib, while the brokerage said the two therapies have appeared comparable on efficacy and that safety could be a differentiating factor longer term.In CRC, RBC said its KOL feedback suggests ORR could range from 45% to 70%, while an ORR in the 80s would be needed to give the community greater comfort in eventual translation to survival.RBC has","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IDNA","BK4532","BK4588","INCY","BK4585","BK4550","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}